KR970704768A - 사람 면역결핍증 바이러스의 증식을 억제하는 화합물 및 방법(Compounds and Methods for Inhibiting Propagation of Human Immunoefficiency Virus) - Google Patents
사람 면역결핍증 바이러스의 증식을 억제하는 화합물 및 방법(Compounds and Methods for Inhibiting Propagation of Human Immunoefficiency Virus)Info
- Publication number
- KR970704768A KR970704768A KR1019970700344A KR19970700344A KR970704768A KR 970704768 A KR970704768 A KR 970704768A KR 1019970700344 A KR1019970700344 A KR 1019970700344A KR 19970700344 A KR19970700344 A KR 19970700344A KR 970704768 A KR970704768 A KR 970704768A
- Authority
- KR
- South Korea
- Prior art keywords
- virus
- human
- immunoefficiency
- compounds
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/277,857 US5733781A (en) | 1994-07-19 | 1994-07-19 | Oligonucleotides and methods for inhibiting propagation of human immunodeficiency virus |
PCT/US1995/009080 WO1996002557A1 (en) | 1994-07-19 | 1995-07-14 | Compounds and methods for inhibiting propagation of human immunodeficiency virus |
Publications (1)
Publication Number | Publication Date |
---|---|
KR970704768A true KR970704768A (ko) | 1997-09-06 |
Family
ID=23062654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970700344A KR970704768A (ko) | 1994-07-19 | 1997-01-18 | 사람 면역결핍증 바이러스의 증식을 억제하는 화합물 및 방법(Compounds and Methods for Inhibiting Propagation of Human Immunoefficiency Virus) |
Country Status (9)
Country | Link |
---|---|
US (1) | US5733781A (ko) |
EP (1) | EP0697414B1 (ko) |
JP (1) | JP3307944B2 (ko) |
KR (1) | KR970704768A (ko) |
AT (1) | ATE228142T1 (ko) |
AU (1) | AU699233B2 (ko) |
CA (1) | CA2194398A1 (ko) |
DE (1) | DE69528867D1 (ko) |
WO (1) | WO1996002557A1 (ko) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2279669A1 (en) * | 1995-12-15 | 1997-06-16 | Enzo Therapeutics, Inc. | Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses |
US6776986B1 (en) | 1996-06-06 | 2004-08-17 | Novartis Ag | Inhibition of HIV-1 replication by antisense RNA expression |
DE69727984T2 (de) * | 1996-07-09 | 2005-01-05 | Canji, Inc., San Diego | Verfahren zur messung viraler infektivität |
US5962665A (en) * | 1997-06-16 | 1999-10-05 | Abbott Laboratories | Nucleic acid primers and probes for detecting HIV-1 and HIV-2 |
US7244570B2 (en) * | 1998-08-04 | 2007-07-17 | Luminex Molecular Diagnostics, Inc. | Methods and compositions for modulating “marginally indiscriminant” hybridizations |
US6867037B1 (en) * | 1998-08-10 | 2005-03-15 | Meiji Dairies Corp. | High level secretory expression system of intact MK family protein |
DE19850186A1 (de) * | 1998-10-30 | 2000-05-25 | Roche Diagnostics Gmbh | Neue Primer und Sonden zum Nachweis von HIV |
AU2487300A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
WO2000046403A2 (en) * | 1999-02-03 | 2000-08-10 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OFHEALT H AND HUMAN SERVICES | Methods and reagents for molecular detection of hiv-1 groups m, n and o |
KR20020069627A (ko) * | 2001-02-27 | 2002-09-05 | 동부한농화학 주식회사 | 육환의 아자슈거를 가진 뉴클레오타이드 유도체를 포함한포스포로티오에이트 올리고뉴클레오타이드 및 이들의에이즈 치료제로서의 새로운 용도 |
CA2452015C (en) | 2001-07-05 | 2012-07-03 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
US6852491B2 (en) * | 2001-09-04 | 2005-02-08 | Abbott Laboratories | Amplification and detection reagents for HIV-1 |
US20050222068A1 (en) * | 2003-10-23 | 2005-10-06 | Mourich Dan V | Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells |
US20060205070A1 (en) * | 2004-01-13 | 2006-09-14 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | HIV TEV compositions and methods of use |
US20060240032A1 (en) * | 2005-03-31 | 2006-10-26 | Hinrichs David J | Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases |
EP2121984A2 (en) * | 2007-03-16 | 2009-11-25 | 454 Life Sciences Corporation | System and method for detection of hiv drug resistant variants |
CA2746508A1 (en) * | 2008-12-17 | 2010-07-15 | Avi Biopharma, Inc. | Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis |
NL2010579C2 (nl) | 2013-04-05 | 2014-10-07 | Thomas Regout Internat B V | Anti-kantelsamenstel voor een reeks van laden in een gereedschapskast. |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023243A (en) * | 1981-10-23 | 1991-06-11 | Molecular Biosystems, Inc. | Oligonucleotide therapeutic agent and method of making same |
GB8423659D0 (en) * | 1984-09-19 | 1984-10-24 | Pasteur Institut | Cloned dna sequences |
NZ209840A (en) * | 1983-10-17 | 1988-11-29 | Kaji Akira | A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action |
US4738922A (en) * | 1984-05-25 | 1988-04-19 | Dana Farber Cancer Institute | Trans-acting transcriptional factors |
IL79391A (en) * | 1985-08-14 | 1994-06-24 | Hughes Aircraft Co | Non-spherical patch with a stepped key and a display system that uses it |
US4752565A (en) | 1986-04-07 | 1988-06-21 | The United States Of America As Represented By The Department Of Health And Human Services | Cell line producing AIDS viral antigens without producing infectious virus particles |
US4806463A (en) * | 1986-05-23 | 1989-02-21 | Worcester Foundation For Experimental Biology | Inhibition of HTLV-III by exogenous oligonucleotides |
US5264423A (en) * | 1987-03-25 | 1993-11-23 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibitors for replication of retroviruses and for the expression of oncogene products |
JP2758184B2 (ja) * | 1987-06-22 | 1998-05-28 | メデバ ホールディングス ベスローテン ベノートスハップ | 肝炎b表面抗原ワクチン |
US5110802A (en) * | 1987-07-14 | 1992-05-05 | City Of Hope | Oligonucleotide phosphonates and method of inhibiting a human immunodeficiency virus in vitro utilizing said oligonucleotide phosphonates |
KR960002561B1 (ko) | 1987-09-21 | 1996-02-22 | 젠-프로우브 인코퍼레이티드 | 균질보호분석법 |
IL89993A0 (en) * | 1988-04-25 | 1989-12-15 | Phillips Petroleum Co | Expression of the hiv 24kda gag protein in methylotrophic yeasts |
US5449769A (en) | 1989-03-06 | 1995-09-12 | Gen-Probe Incorporated | Method and reagent for sulfurization of organophosphorous compounds |
ES2262166T3 (es) * | 1989-06-02 | 2006-11-16 | Institut Pasteur | Sintesis de proteinas o polipeptidos codificados por un secuencia nucleotidica vih-1, vih-2 o siv. |
US5144019A (en) * | 1989-06-21 | 1992-09-01 | City Of Hope | Ribozyme cleavage of HIV-I RNA |
WO1991010746A1 (en) * | 1990-01-10 | 1991-07-25 | Chiron Corporation | Dna-dependent rna polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays |
US5166195A (en) * | 1990-05-11 | 1992-11-24 | Isis Pharmaceuticals, Inc. | Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides |
DE69130331T2 (de) | 1990-10-26 | 1999-03-04 | Genta Inc | Verbessertes verfahren zur synthese von oligomeren |
AU1741692A (en) * | 1991-03-13 | 1992-10-21 | Regents Of The University Of California, The | Detection of 3'-azido-3'-deoxythymidine resistance |
FR2677039B1 (fr) * | 1991-05-31 | 1994-09-09 | Cis Bio Int | Oligonucleotides, utilisables comme reactifs pour la detection in vitro des infections a retrovirus de type hiv et procede de detection de retrovirus de type hiv. |
US5226326A (en) * | 1991-05-31 | 1993-07-13 | Environmental Stress Screening Corp. | Vibration chamber |
PT726962E (pt) * | 1991-12-23 | 2006-10-31 | Chiron Corp | Sondas para hiv para uso em ensaios de hibridacao em sanduiche em fase de solucao |
US5585479A (en) * | 1992-07-24 | 1996-12-17 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human ELAM-I RNA |
JPH08504570A (ja) * | 1992-10-05 | 1996-05-21 | ハイブライドン インコーポレイテッド | 治療用抗hivオリゴヌクレオチドと薬剤 |
CA2159103C (en) * | 1993-03-26 | 2002-03-12 | Sherrol H. Mcdonough | Detection of human immunodeficiency virus type 1 |
US8328553B2 (en) | 2006-03-09 | 2012-12-11 | 3M Innovative Properties Company | Device for dispensing material |
CN101689633A (zh) | 2007-05-08 | 2010-03-31 | 加利福尼亚大学董事会 | 高放电倍率锂离子电池 |
US8803361B2 (en) | 2011-01-19 | 2014-08-12 | Schneider Electric It Corporation | Apparatus and method for providing uninterruptible power |
US9202037B2 (en) | 2012-06-08 | 2015-12-01 | General Electric Company | System and method for using machine readable code to commission device applications |
-
1994
- 1994-07-19 US US08/277,857 patent/US5733781A/en not_active Expired - Lifetime
-
1995
- 1995-07-14 WO PCT/US1995/009080 patent/WO1996002557A1/en not_active Application Discontinuation
- 1995-07-14 JP JP50524296A patent/JP3307944B2/ja not_active Expired - Fee Related
- 1995-07-14 CA CA002194398A patent/CA2194398A1/en not_active Abandoned
- 1995-07-14 AU AU31354/95A patent/AU699233B2/en not_active Ceased
- 1995-07-19 AT AT95111359T patent/ATE228142T1/de not_active IP Right Cessation
- 1995-07-19 DE DE69528867T patent/DE69528867D1/de not_active Expired - Lifetime
- 1995-07-19 EP EP95111359A patent/EP0697414B1/en not_active Expired - Lifetime
-
1997
- 1997-01-18 KR KR1019970700344A patent/KR970704768A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU699233B2 (en) | 1998-11-26 |
CA2194398A1 (en) | 1996-02-01 |
WO1996002557A1 (en) | 1996-02-01 |
JP3307944B2 (ja) | 2002-07-29 |
ATE228142T1 (de) | 2002-12-15 |
DE69528867D1 (de) | 2003-01-02 |
AU3135495A (en) | 1996-02-16 |
US5733781A (en) | 1998-03-31 |
EP0697414A1 (en) | 1996-02-21 |
EP0697414B1 (en) | 2002-11-20 |
JPH10501421A (ja) | 1998-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR970704768A (ko) | 사람 면역결핍증 바이러스의 증식을 억제하는 화합물 및 방법(Compounds and Methods for Inhibiting Propagation of Human Immunoefficiency Virus) | |
DE69432635D1 (de) | Oligonukleotide mit wirkung gegen den menschlichen immunodefiziens-virus | |
AP1782A (en) | Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus. | |
MY138860A (en) | Hiv protease inhibitors. | |
ATE142873T1 (de) | Hemmung einer virusinfektion | |
DE69609720T2 (de) | Wegwerfbares sicherheitsskalpell | |
ATE146968T1 (de) | Verwendung von funkionellen derivaten des interzellulär-adhäsions-moleküls icam-1 in einer antivirus-therapie | |
LV12719A (lv) | Benzoxazinones as inhibitors of hiv reverse transcriptase | |
ATE312079T1 (de) | Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion | |
ES2191075T3 (es) | 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido-(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infecciones por hiv. | |
HUP0400500A2 (hu) | Vírusos fertőzések kezelése Levovirin TM alkalmazásával | |
DE3853672T2 (de) | Nichtzurückschlagende RNS-Viren. | |
EE03514B1 (et) | Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon | |
DE69921530D1 (de) | Behandlung einer Virusinfektion bei Schweinen | |
AU2880595A (en) | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
NO965556L (no) | Trippelkombinasjon mot HIV | |
NO965591D0 (no) | Kombinasjonsbehandling av HIV-infeksjon | |
WO1997026880A3 (en) | Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients | |
SE9402241L (sv) | Inhibitor | |
WO1998044913A3 (en) | Compositions containing mkc-442 in combination with other antiviral agents | |
AP9801368A0 (en) | Benzamide treatment of mentia associated with HIV AIDS VIRUS (HIV-1) infection | |
NO960551D0 (no) | Antistoff basert behandling av HIV infeksjon | |
ATE237616T1 (de) | Verwendung von (1r,4s)-4-(6-amino-9h-purin-9-yl)- 2-cyclopenten-1-methanol in hbv | |
CA2155129A1 (en) | Combinations of Retroviral Inhibitors | |
AU2880495A (en) | Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |